Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)

NCT00111423 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
216
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen